Acute Eosinophilic Pneumonia

Acute Eosinophilic Pneumonia (AEP) is a rare and potentially life-threatening condition characterized by the rapid accumulation of eosinophils—a type of white blood cell—in the lungs. This condition is part of a broader category of diseases known as eosinophilic lung diseases, which involve the proliferation of eosinophils in the lung tissues and airways. AEP is distinguished by its acute onset and severe symptoms, which can include fever, difficulty breathing (dyspnea), and hypoxemia (low blood oxygen levels).

Etiology

The exact cause of Acute Eosinophilic Pneumonia is not well understood, but it is believed to be a hypersensitivity reaction to an inhaled agent. Potential triggers include cigarette smoke, dust, pollen, and certain medications. Unlike Chronic Eosinophilic Pneumonia (CEP), which may have a more insidious onset, AEP develops rapidly and requires immediate medical attention.

Pathophysiology

In AEP, eosinophils are recruited to the lungs in response to an unknown trigger. These cells release toxic substances that cause damage to the lung tissue, leading to inflammation and the accumulation of fluid (edema) in the alveolar spaces. This process impairs gas exchange and can lead to respiratory failure if not promptly treated.

Clinical Presentation

Patients with Acute Eosinophilic Pneumonia typically present with acute respiratory distress that develops over a period of days. Symptoms may include:

- High fever - Cough - Dyspnea - Chest pain - General malaise

Physical examination may reveal signs of respiratory distress, such as tachypnea (rapid breathing), use of accessory muscles for breathing, and cyanosis (bluish discoloration of the skin due to low oxygen levels).

Diagnosis

The diagnosis of AEP is based on clinical presentation, laboratory findings, and imaging studies. Key diagnostic tests include:

- **Complete blood count (CBC)**: May show elevated eosinophil count. - **Chest X-ray** and **CT scan**: Typically reveal diffuse infiltrates, which are indicative of fluid accumulation in the alveolar spaces. - **Bronchoalveolar lavage (BAL)**: A procedure that involves washing out the airspaces of the lung with saline and analyzing the fluid. A high percentage of eosinophils in the BAL fluid is diagnostic of AEP. - **Pulmonary function tests**: May show a restrictive pattern due to the inflammation and edema in the lungs.

Treatment

The mainstay of treatment for Acute Eosinophilic Pneumonia is corticosteroids, which help to reduce inflammation and eosinophil activity in the lungs. Patients often show rapid improvement with steroid therapy. In severe cases, supplemental oxygen or mechanical ventilation may be required to support breathing until the inflammation resolves.

Prognosis

With prompt recognition and treatment, the prognosis for patients with AEP is generally excellent. Most individuals recover completely with no lasting effects on lung function. However, delayed treatment can lead to respiratory failure and other complications.

Prevention

Since the exact cause of Acute Eosinophilic Pneumonia is often unknown, specific prevention strategies are not well established. Avoiding known triggers, such as smoking, may reduce the risk of developing the condition.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian